VICAM

is a leading player in the global market for rapid food safety diagnostics for field and laboratory applications. Established in 1987 by Harvard and MIT scientists, alongside agribusiness executives, VICAM successfully brought its flagship immunoaffinity column for the swift detection of aflatoxin to the commercial arena. Since being acquired by Waters Corporation in 2006, VICAM has solidified its global standing as a developer of speedy diagnostic solutions. Waters Corporation, renowned as the foremost specialist in measurement technologies aimed at enhancing human health and well-being, operates under the guiding principle of 'Deliver Benefit.' With a legacy spanning over six decades, the company has been a pioneering force in chromatography, mass spectrometry, and thermal analysis technologies. Its impact spans pharmaceutical discoveries, food and water safety assurance, and chemical entity integrity. The industries that VICAM and Waters Corporation are involved in are Biotechnology and Manufacturing. Waters Corporation maintains a significant global presence, with over 7,000 employees across 35 countries, including 15 manufacturing facilities, and its products available in more than 100 countries. Although specific details about VICAM's headquarter location and recent investment information are currently unavailable, the company and its parent organization, Waters Corporation, continue to play a pivotal role in the advancement of rapid diagnostic solutions for food safety on the global stage.